Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China flag China · Delayed Price · Currency is CNY
12.82
-0.31 (-2.36%)
Nov 18, 2026, 3:00 PM CST

SHA:605266 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
8,1378,4078,6468,5377,0624,863
Other Revenue
513.57513.57636.61543.85452.91371.79
8,6518,9219,2839,0817,5145,235
Revenue Growth
-4.90%-3.90%2.23%20.84%43.54%17.21%
Cost of Revenue
5,7165,7265,9935,8454,8293,373
Gross Profit
2,9353,1953,2903,2362,6851,862
Selling, General & Admin
2,8702,7942,9382,5882,1211,478
Other Operating Expenses
23.510.8626.1110.6413.46-3.22
Operating Expenses
2,9102,8262,9652,5962,1391,475
Operating Income
25.28368.73324.7639.62546.65386.78
Interest Expense
-30.94-120.72-135.37-121.23-99.92-49.8
Interest & Investment Income
0.823.365.757.047.7713.67
Currency Exchange Gain (Loss)
0.690.46-0.1---
Other Non Operating Income (Expenses)
-195.37-13.04-11.35-12.52-9.14-6.99
EBT Excluding Unusual Items
-199.52238.79183.62512.91445.36343.66
Impairment of Goodwill
-34.52-34.52-11.01-4.77-4.64-
Gain (Loss) on Sale of Investments
-6.01-7.46-9.1-7.94--
Gain (Loss) on Sale of Assets
21.866.177.269.85-1.090.19
Asset Writedown
7.74-----
Other Unusual Items
114.17-1.8212.641.114.38
Pretax Income
-199.45207.16168.95522.7440.74358.23
Income Tax Expense
11.9159.0440.99108.2166.2858.97
Earnings From Continuing Operations
-211.36148.12127.96414.49374.46299.26
Minority Interest in Earnings
0.10.030.17-0.07-0.171.27
Net Income
-211.26148.15128.13414.41374.29300.53
Net Income to Common
-211.26148.15128.13414.41374.29300.53
Net Income Growth
-15.63%-69.08%10.72%24.55%19.66%
Shares Outstanding (Basic)
148148154154151140
Shares Outstanding (Diluted)
148148154155152140
Shares Change
-3.77%-4.03%-0.17%1.91%8.55%21.58%
EPS (Basic)
-1.421.000.832.692.482.15
EPS (Diluted)
-1.421.000.832.682.472.15
EPS Growth
-20.48%-69.03%8.65%14.74%-1.58%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
931.241,025241.05724.37409.93358.87
Free Cash Flow Per Share
6.286.921.564.682.702.57
Dividend Per Share
1.2701.2701.1001.0710.9360.777
Dividend Growth
15.46%15.46%2.73%14.41%20.51%-10.98%
Gross Margin
33.93%35.82%35.44%35.64%35.73%35.57%
Operating Margin
0.29%4.13%3.50%7.04%7.27%7.39%
Profit Margin
-2.44%1.66%1.38%4.56%4.98%5.74%
Free Cash Flow Margin
10.76%11.49%2.60%7.98%5.46%6.86%
EBITDA
93.59440.07400.08707.38599.54417.79
EBITDA Margin
1.08%4.93%4.31%7.79%7.98%7.98%
D&A For EBITDA
68.3171.3475.3867.7652.8931.01
EBIT
25.28368.73324.7639.62546.65386.78
EBIT Margin
0.29%4.13%3.50%7.04%7.27%7.39%
Effective Tax Rate
-28.50%24.26%20.70%15.04%16.46%
Revenue as Reported
2,3728,9219,2839,0817,5145,235
Advertising Expenses
-15.9128.6225.623.1718.16